Desvenlafaxine Extended Release Tablets 50Mg – DESQUIL 50 Tablets

DESQUIL 50 Tablets – Advanced SNRI Therapy for Depression and Cognitive Health.

DESQUIL 50 Tablets – Desvenlafaxine Extended Release Tablets 50Mg is a potent SNRI (serotonin-norepinephrine reuptake inhibitor), approved for the treatment of major depressive disorder. It enhances neurotransmitter activity in the CNS to improve mood, motivation, and overall functioning. The extended-release (ER) formulation ensures gradual absorption, maintaining stable plasma concentrations throughout the day. It also enhances patient compliance by reducing the need for multiple daily doses.

Key Benefits of Desvenlafaxine Extended Release Tablets – DESQUIL 50 Tablets
✅ Long-Lasting Control – The extended-release design maintains steady drug levels in the body, reducing the need for frequent dosing and helping prevent mood swings.
✅ Enhanced Dual Mechanism – Acts on both serotonin and norepinephrine pathways, boosting mood, energy, and mental clarity in patients with major depressive disorder (MDD).
✅ Better Tolerability Profile – Associated with fewer issues like sexual dysfunction, weight changes, or drowsiness, making it a favourable option for sustained treatment.

Recommended By Specialists:
👨‍⚕️ Psychiatrists: Specifically prescribed for depression, anxiety disorders, and other mood disorders.
👨‍⚕️ Neurologists: In some cases, for neuropathic pain or headache disorders (off-label use).
👨‍⚕️ General Physicians: For managing mild to moderate depression when psychiatric referral isn’t immediately available.

INDICATIONS:
✅ Major Depressive Disorder (MDD)
✅ Anxiety Disorders
✅ Menopausal Vasomotor Symptoms
✅ Neuropathic Pain (Off-label use)
✅ Chronic Fatigue Associated with Depression